Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

FDA Approves PhotoMedex Laser System for Dermatitis

Photonics.com
Aug 2001
RADNOR, Pa., Aug. 15 -- PhotoMedex Inc. has received US Food and Drug Administration (FDA) clearance to market the XTRAC laser system to treat atopic dermatitis. Atopic dermatitis, or eczema, is a chronic inflammation of the skin that can afflict persons of any age, but is considered to be the most common skin disease in children under the age of 11.
   Jeff O'Donnell, President and CEO, commented, "We are very pleased to have received approval from the FDA so quickly. With 15 million Americans suffering from the disease, the ability to now treat eczema is another significant opportunity to expand the treatment platform for our XTRAC laser."


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.